可乐定
可乐定(英語:)(商品名稱為:Catapres, Kapvay, Nexiclon, Clophelin等),是一种用来治疗高血压、注意力缺陷多动障碍、焦虑症、抽動綜合症、偏头痛、「酒精、鴉片、尼古丁的戒斷症狀」、更年期潮熱、腹泻和特定类型疼痛的药物。可乐定歸類為α2腎上腺受體活化劑和imidazoline受體活化劑。可樂定被应用于临床已有超过40年的历史。 [4] [5]
![]() | |
![]() | |
| 系统(IUPAC)命名名称 | |
|---|---|
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine | |
| 临床数据 | |
| 商品名 | Catapres, Kapvay, Nexiclon |
| Drugs.com | Monograph |
| MedlinePlus | a682243 |
| 医疗法规 | |
| 妊娠分级 | |
| 给药途径 | 口服,硬膜外给药,静脉注射等 |
| 合法狀態 | |
| 合法状态 |
|
| 药代动力学数据 | |
| 生物利用度 | 75-95% (oral), 60-70% (transdermal)[1] |
| 蛋白结合度 | 20-40%[2] |
| 代谢 | Hepatic至inactive metabolites,[2] 2/3 CYP2D6 |
| 生物半衰期 | IR: 12-16 hours,[3] 14 hours for repeated dosing[1] |
| 排泄 | 尿液 (72%)[2] |
| 识别 | |
| CAS注册号 | 4205-90-7 |
| ATC代码 | C02AC01 N02, S01 |
| PubChem | CID 2803 |
| IUPHAR/BPS | 516 |
| DrugBank | DB00575 |
| ChemSpider | 2701 |
| UNII | MN3L5RMN02 |
| KEGG | D00281 |
| ChEBI | CHEBI:3757 |
| ChEMBL | CHEMBL134 |
| 化学 | |
| 化学式 | C9H9Cl2N3 |
| 摩尔质量 | 230.093 g/mol |
| |
| |
引用
- Lowenthal, DT; Matzek, KM; MacGregor, TR. . Clinical Pharmacokinetics. May 1988, 14 (5): 287–310. PMID 3293868. doi:10.2165/00003088-198814050-00002.
- . Medscape Reference. WebMD. [10 November 2013].
- . [2016-06-11]. (原始内容存档于2017-10-12).
- Brayfield, A (编). . Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. 13 January 2014 [28 June 2014].
- Neil, MJ. . Current Clinical Pharmacology. November 2011, 6 (4): 280–7. PMID 21827389. doi:10.2174/157488411798375886.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

